02392nas a2200205   4500008004100000020002200041245009600063210006900159260002400228300001200252520162000264100002801884700002001912700003201932700002801964700002001992700002902012700002302041856012202064       2019                        eng d  a978-981-13-8315-100aDistribution and bioprospecting potential of actinobacteria from Indian mangrove ecosystems0 aDistribution and bioprospecting potential of actinobacteria from  bSpringer, Singapore  a319-3533 aActinobacteria are the ecologically and economically important prokaryotes with the unprecedented ability to produce novel metabolites. They are widely distributed in nature due to their physiological and metabolic versatility. Actinobacteria from marine ecosystem are recognized as a promising source for novel bioactive metabolites. Notably, mangroves are the most fertile and productive marine ecosystem due to their ecophysiological conditions and vast microbial diversity. At the global level, there are many novel actinobacteria which have been reported from mangrove ecosystems and also explored for their bioprospecting potential. However, in India, microbiologists have explored actinobacteria from selected mangrove ecosystems for the past five decades with special reference to culturable diversity and antimicrobial, antimycobacterial, anticancer, and enzymatic activities. So far, around 22 rare actinobacterial genera have been reported from the Indian mangrove ecosystems. However, several other novel actinobacteria with promising bioprospecting potential are yet to be explored. Hence, research on actinobacteria in the Indian mangrove ecosystem is still in its infancy. This chapter will describe the exploratory research work carried out on the importance, diversity, antimicrobial and enzymatic activity, biodegradation, and nanotechnological potency of actinobacteria from the Indian mangrove ecosystems. This chapter will enable researchers to identify the gaps to be bridged for further research on Indian mangrove actinobacteria and exploit their potential to the maximum benefit to mankind.1 aManikkam, Radhakrishnan1 aPati, Premalata1 aThangavel, Shanmugasundaram1 aVenugopal, Gopikrishnan1 aJoseph, Jerrine1 aRamasamy, Balagurunathan1 aDastager, Syed, G.  uhttp://library.ncl.res.in/content/distribution-and-bioprospecting-potential-actinobacteria-indian-mangrove-ecosystems02605nas a2200265   4500008004100000022001400041245016900055210006900224260000800293300001100301490000700312520164400319653000601963653002601969653001801995653003102013653002802044100002502072700002802097700002202125700002202147700001902169700002302188856012802211       2022                        eng d  a1018-364700a2,4-Di-tert-butylphenol (2,4-DTBP) purified from streptomyces sp. KCA1 from phyllanthus niruri: isolation, characterization, antibacterial and anticancer properties0 a24Ditertbutylphenol 24DTBP purified from streptomyces sp KCA1 fr  cJUL  a1020880 v343 a<p>
	Objectives: The present study reports the bioactivity of 2,4-Di-tert-butylphenol (2,4-DTBP) purified from an endophytic Streptomyces species KCA1 isolated from the leaves of Phyllanthus niruri and its antibacterial and anticancer properties. Methods: The extracellular metabolites were produced from the strain KCA1 by submerged fermentation using ethyl acetate. The crude extract was further evaluated for antibacterial activity against set of pathogens. Active metabolite from the extract was purified using chromatography techniques and detected its antibacterial activity by disc diffusion assay. The molecular structure of the active molecule was identified through various spectral study. Moreover, the bioactive metabolite 2,4-DTBP was analyzed antibacterial and anti-proliferative activity. Results: Strain KCA1 was identified as Streptomyces sp. In the preliminary screening, the crude extract exhibited broad spectrum activity against various bacterial pathogens. Based on the spectral properties, the active metabolite was identified as 2,4-Di-tert-butylphenol. The MIC of active compound 2,4-DTBP inhibited E. coli ATCC 25922 and S. aureus ATCC 29213 at 50 lg/ml and 0.78 lg/ml, respectively. The IC50 value of 2,4-DTBP was found to be 11.0 lg/ml and 116.8 lg/ml, against breast cancer cell line (MCF7) and normal VERO cell line, respectively. Conclusions: This study concluded that 2,4-DTBP, produced from the endophytic Streptomyces sp. KCA1, is the potential candidate to develop as promising antibacterial and anticancer agent. (C) 2022 The Authors. Published by Elsevier B.V. on behalf of King Saud University.</p>
10a210a4-Di-tert-butylphenol10aAntibacterial10aantiproliferative activity10aEndophytic Streptomyces1 aSeenivasan, Ayswarya1 aManikkam, Radhakrishnan1 aKaari, Manigundan1 aSahu, Amit, Kumar1 aSaid, Madhukar1 aDastager, Syed, G.  uhttp://library.ncl.res.in/content/24-di-tert-butylphenol-24-dtbp-purified-streptomyces-sp-kca1-phyllanthus-niruri-isolation